The DOI matches its Crossref record; 516 of the 516 references it cites were found in a registry or an index.
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Open accessAbstract
SUMMARY: A select group of microorganisms inhabit the airways of individuals with cystic fibrosis. Once established within the pulmonary environment in these patients, many of these microbes adapt by altering aspects of their structure and physiology. Some of these microbes and adaptations are associated with more rapid deterioration in lung function and overall clinical status, whereas others appear to have little effect. Here we review current evidence supporting or refuting a role for the different microbes and their adaptations in contributing to poor clinical outcomes in cystic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in cases where P. aeruginosa and S. aureus have been co-isolated, both pathogens seem to contribute independently and additively to the disease severity (Sagel et al., 2009; Hauser et al., 2011), presenting as increased lung inflammation and consequently increased lung damage compared to infection with a single pathogen (Sagel et al., 2009).”
From In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. (2017) · cites this paper as Hauser et al., 2011
In the citing paper
“While, S. aureus is mostly acquired during childhood, the presence of P. aeruginosa is associated with increasing age and worsening patient prognosis (Sagel et al., 2009; Hauser et al., 2011; Cystic Fibrosis Foundation, 2014).”
From In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. (2017) · cites this paper as Hauser et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Marcos, V., Zhou, Z., Yildirim, A. Ö., Bohla, A., Hector, A., Vitkov, L., Wiedenbauer, E.-M., Krautgartner, W. D., Stoiber, W., Belohradsky, B. H., et al. (2010) · Nature Medicine · doi:10.1038/nm.2209 · Cited by 212
RetractedBacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Webb, A. K. (2006) · Cited by 4,369
Mechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Antibiotic resistance of bacterial biofilms
Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., & Ciofu, O. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.011 · Cited by 3,225
Nährlich, L., Mainz, J. G., Adams, C., Engel, C., Herrmann, G., Icheva, V., Lauer, J., Deppisch, C., Wirth, A., Unger, K., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350071 · Cited by 2,525
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Early pulmonary inflammation in infants with cystic fibrosis.
Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J., & Riches, D. W. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697234 · Cited by 1,263
Type IV Pili and Twitching Motility
Mattick, J. S. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160938 · Cited by 1,255
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Matsui, H., Grubb, B. R., Tarran, R., Randell, S. H., Gatzy, J. T., Davis, C. W., & Boucher, R. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81724-9 · Cited by 1,169
CYSTIC FIBROSIS OF THE PANCREAS AND ITS RELATION TO CELIAC DISEASE: A CLINICAL AND PATHOLOGIC STUDY
ANDERSEN, D. H. (1938) · American Journal of Diseases of Children · doi:10.1001/archpedi.1938.01980140114013 · Cited by 1,146
Schuster, M., Lostroh, C. P., Ogi, T., & Greenberg, E. P. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.7.2066-2079.2003 · Cited by 1,126
Bacterial lipopolysaccharides and innate immunity
Alexander, C., & Rietschel, E. T. (2001) · Journal of Endotoxin Research · doi:10.1179/096805101101532675 · Cited by 1,120
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U. E., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiß, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13870 · Cited by 1,099
Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid
Smith, J. J., Travis, S. M., Greenberg, E. P., & Welsh, M. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81099-5 · Cited by 1,039
Emerson, J., Rosenfeld, M., McNamara, S., Ramsey, B., & Gibson, R. L. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10127 · Cited by 1,007
Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
Drenkard, E., & Ausubel, F. M. (2002) · Nature · doi:10.1038/416740a · Cited by 997
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 968
Self-citationYabuuchi, E., Kosako, Y., Oyaizu, H., Yano, I., Hotta, H., Hashimoto, Y., Ezaki, T., & Arakawa, M. (1992) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1992.tb02129.x · Cited by 944
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiss, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213870 · Cited by 932
Wagner, V. E., Bushnell, D., Passador, L., Brooks, A. I., & Iglewski, B. H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.7.2080-2095.2003 · Cited by 920
Ratjen, F., & Döring, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12567-6 · Cited by 885
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
Denton, M., & Kerr, K. G. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.57 · Cited by 852
Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
Isles, A., Maclusky, I., Corey, M., Gold, R., Prober, C., Fleming, P., & Levison, H. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80993-2 · Cited by 846
Primary Ciliary Dyskinesia: Diagnostic and Phenotypic Features
Noone, P. G., Leigh, M. W., Sannuti, A., Minnix, S. L., Carson, J. L., Hazucha, M., Zariwala, M. A., & Knowles, M. R. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200303-365oc · Cited by 843
Cooperation and conflict in quorum-sensing bacterial populations
Diggle, S. P., Griffin, A. S., Campbell, G. S., & West, S. A. (2007) · Nature · doi:10.1038/nature06279 · Cited by 837
The Changing Microbial Epidemiology in Cystic Fibrosis
LiPuma, J. J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-09 · Cited by 806
Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M., & Høiby, N. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21011 · Cited by 795
Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat
Zetola, N., Francis, J. S., Nuermberger, E. L., & Bishai, W. R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70112-2 · Cited by 791
Stevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., Judson, M. A., Denning, D. W., Crameri, R., Brody, A. S., Light, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376525 · Cited by 790
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
Effect of High-Dose Ibuprofen in Patients with Cystic Fibrosis
Konstan, M. W., Byard, P. J., Hoppel, C. L., & Davis, P. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321303 · Cited by 726
Inflammatory cytokines in cystic fibrosis lungs.
Bonfield, T. L., Panuska, J. R., Konstan, M. W., Hilliard, K. A., Hilliard, J. B., Ghnaim, H., & Berger, M. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.6.8520783 · Cited by 711
Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.
Shak, S., Capon, D. J., Hellmiss, R., Marsters, S. A., & Baker, C. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9188 · Cited by 707
Alginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M., & Parsek, M. R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5395-5401.2001 · Cited by 693
Role of mutator alleles in adaptive evolution
Taddei, F., Radman, M., Maynard-Smith, J., Toupance, B., Gouyon, P. H., & Godelle, B. (1997) · Nature · doi:10.1038/42696 · Cited by 677
Davis, P. B. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-840oe · Cited by 670
Self-generated diversity produces “insurance effects” in biofilm communities
Boles, B. R., Thoendel, M., & Singh, P. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407460101 · Cited by 670
Parsek, M. R., & Greenberg, E. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8789 · Cited by 652
Lam, J., Chan, R., Lam, K., & Costerton, J. W. (1980) · Infection and Immunity · doi:10.1128/iai.28.2.546-556.1980 · Cited by 649
A network of networks: Quorum-sensing gene regulation in Pseudomonas aeruginosa
Schuster, M., & Peter Greenberg, E. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2006.01.036 · Cited by 646
Nontuberculous Mycobacteria: I: Multicenter Prevalence Study in Cystic Fibrosis
Olivier, K. N., Weber, D. J., Wallace, R. J., Faiz, A. R., Lee, J.-H., Zhang, Y., Brown-Elliot, B. A., Handler, A., Wilson, R. W., Schechter, M. S., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-678oc · Cited by 631
Casadevall, A., & Pirofski, L.-A. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6511-6518.2000 · Cited by 613
Yankaskas, J. R., Marshall, B. C., Sufian, B., Simon, R. H., & Rodman, D. (2004) · Chest · doi:10.1378/chest.125.1_suppl.1s · Cited by 579
Human Toll-like receptor 4 recognizes host-specific LPS modifications
Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B., & Miller, S. I. (2002) · Nature Immunology · doi:10.1038/ni777 · Cited by 579
Longitudinal Assessment of Pseudomonas aeruginosa in Young Children with Cystic Fibrosis
Burns, J. L., Gibson, R. L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R., Smith, A. L., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318075 · Cited by 555
Konstan, M. W., Hilliard, K. A., Norvell, T. M., & Berger, M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.2.8049828 · Cited by 520
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
Sanders, D. B., Bittner, R. C. L., Rosenfeld, M., Hoffman, L. R., Redding, G. J., & Goss, C. H. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1421oc · Cited by 519
Management of Pulmonary Disease in Patients with Cystic Fibrosis
Ramsey, B. W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350307 · Cited by 502
Mahenthiralingam, E., Bischof, J., Byrne, S. K., Radomski, C., Davies, J. E., Av-Gay, Y., & Vandamme, P. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3165-3173.2000 · Cited by 500
Vandamme, P., Holmes, B., Vancanneyt, M., Coenye, T., Hoste, B., Coopman, R., Revets, H., Lauwers, S., Gillis, M., Kersters, K., et al. (1997) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-47-4-1188 · Cited by 496
Nakamura, H., Yoshimura, K., McElvaney, N. G., & Crystal, R. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115738 · Cited by 487
Specific Lipopolysaccharide Found in Cystic Fibrosis Airway Pseudomonas aeruginosa
Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., & Miller, S. I. (1999) · Science · doi:10.1126/science.286.5444.1561 · Cited by 484
Social cheating in Pseudomonas aeruginosa quorum sensing
Sandoz, K. M., Mitzimberg, S. M., & Schuster, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705653104 · Cited by 480
Frederiksen, B., Koch, C., & Høiby, N. (1997) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199705)23:5<330::aid-ppul4>3.0.co;2-o · Cited by 473
Stenotrophomonas, a New Bacterial Genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983
Palleroni, N. J., & Bradbury, J. F. (1993) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-43-3-606 · Cited by 471
Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis
Tunney, M. M., Field, T. R., Moriarty, T. F., Patrick, S., Doering, G., Muhlebach, M. S., Wolfgang, M. C., Boucher, R., Gilpin, D. F., McDowell, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1151oc · Cited by 468
Lower Airway Inflammation in Infants and Young Children with Cystic Fibrosis
ARMSTRONG, D. S., GRIMWOOD, K., CARLIN, J. B., CARZINO, R., GUTIÈRREZ, J. P., HULL, J., OLINSKY, A., PHELAN, E. M., ROBERTSON, C. F., & PHELAN, P. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.96-11058 · Cited by 467
Hoffman, L. R., Déziel, E., D'Argenio, D. A., Lépine, F., Emerson, J., McNamara, S., Gibson, R. L., Ramsey, B. W., & Miller, S. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606756104 · Cited by 467
Hancock, R. E., Mutharia, L. M., Chan, L., Darveau, R. P., Speert, D. P., & Pier, G. B. (1983) · Infection and Immunity · doi:10.1128/iai.42.1.170-177.1983 · Cited by 461
Déziel, E., Comeau, Y., & Villemur, R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.4.1195-1204.2001 · Cited by 459
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Dorkin, H. L., Eisenberg, J. D., Gibson, R. L., Harwood, I. R., Kravitz, R. M., Schidlow, D. V., Wilmott, R. W., Astley, S. J., McBurnie, M. A., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282403 · Cited by 458
Roy‐Burman, A., Savel, R. H., Racine, S., Swanson, B. L., Revadigar, N. S., Fujimoto, J., Sawa, T., Frank, D. W., & Wiener‐Kronish, J. P. (2001) · The Journal of Infectious Diseases · doi:10.1086/320737 · Cited by 455
Feltman, H., Schulert, G., Khan, S., Jain, M., Peterson, L., & Hauser, A. R. (2001) · Microbiology · doi:10.1099/00221287-147-10-2659 · Cited by 446
Self-citationWillner, D., Furlan, M., Haynes, M., Schmieder, R., Angly, F. E., Silva, J., Tammadoni, S., Nosrat, B., Conrad, D., & Rohwer, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007370 · Cited by 441
Role of Mutant CFTR in Hypersusceptibility of Cystic Fibrosis Patients to Lung Infections
Pier, G. B., Grout, M., Zaidi, T. S., Olsen, J. C., Johnson, L. G., Yankaskas, J. R., & Goldberg, J. B. (1996) · Science · doi:10.1126/science.271.5245.64 · Cited by 440
Konstan, M. W., Morgan, W. J., Butler, S. M., Pasta, D. J., Craib, M. L., Silva, S. J., Stokes, D. C., Wohl, M. E. B., Wagener, J. S., Regelmann, W. E., et al. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.03.006 · Cited by 438
Persistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437
Nontuberculous mycobacteria in the environment
Falkinham, J. O. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(02)00014-x · Cited by 434
DiMango, E., Zar, H. J., Bryan, R., & Prince, A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118275 · Cited by 433
Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis
Nixon, G. M., Armstrong, D. S., Carzino, R., Carlin, J. B., Olinsky, A., Robertson, C. F., & Grimwood, K. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.112897 · Cited by 432
Taxonomy and Identification of the Burkholderia cepacia Complex
Coenye, T., Vandamme, P., Govan, J. R. W., & LiPuma, J. J. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.10.3427-3436.2001 · Cited by 432
Microbiology of Sputum from Patients at Cystic Fibrosis Centers in the United States
Burns, J. L., Emerson, J., Stapp, J. R., Yim, D. L., Krzewinski, J., Louden, L., Ramsey, B. W., & Clausen, C. R. (1998) · Clinical Infectious Diseases · doi:10.1086/514631 · Cited by 421
Autolysis and Autoaggregation in Pseudomonas aeruginosa Colony Morphology Mutants
D'Argenio, D. A., Calfee, M. W., Rainey, P. B., & Pesci, E. C. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.23.6481-6489.2002 · Cited by 416
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
Esther, C. R., Esserman, D. A., Gilligan, P., Kerr, A., & Noone, P. G. (2010) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.12.001 · Cited by 410
Mahenthiralingam, E., Campbell, M. E., & Speert, D. P. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.596-605.1994 · Cited by 408
Jensen, P. Ø., Bjarnsholt, T., Phipps, R., Rasmussen, T. B., Calum, H., Christoffersen, L., Moser, C., Williams, P., Pressler, T., Givskov, M., et al. (2007) · Microbiology · doi:10.1099/mic.0.2006/003863-0 · Cited by 404
Kosorok, M. R., Zeng, L., West, S. E. H., Rock, M. J., Splaingard, M. L., Laxova, A., Green, C. G., Collins, J., & Farrell, P. M. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.2009.abs · Cited by 400
Starkey, M., Hickman, J. H., Ma, L., Zhang, N., De Long, S., Hinz, A., Palacios, S., Manoil, C., Kirisits, M. J., Starner, T. D., et al. (2009) · Journal of Bacteriology · doi:10.1128/jb.00119-09 · Cited by 399
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis*
Rosenfeld, M., Gibson, R. L., McNamara, S., Emerson, J., Burns, J. L., Castile, R., Hiatt, P., McCoy, K., Wilson, C. B., Inglis, A., et al. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1144 · Cited by 395
Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
Martin, D. W., Schurr, M. J., Mudd, M. H., Govan, J. R., Holloway, B. W., & Deretic, V (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8377 · Cited by 392
Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
Birrer, P., McElvaney, N. G., Rüdeberg, A., Sommer, C. W., Liechti-Gallati, S., Kraemer, R., Hubbard, R., & Crystal, R. G. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.1.7912987 · Cited by 382
Amin, R., Dupuis, A., Aaron, S. D., & Ratjen, F. (2010) · Chest · doi:10.1378/chest.09-1103 · Cited by 376
Wilson, R., Sykes, D. A., Watson, D., Rutman, A., Taylor, G. W., & Cole, P. J. (1988) · Infection and Immunity · doi:10.1128/iai.56.9.2515-2517.1988 · Cited by 374
Harris, J. K., De Groote, M. A., Sagel, S. D., Zemanick, E. T., Kapsner, R., Penvari, C., Kaess, H., Deterding, R. R., Accurso, F. J., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709804104 · Cited by 372
Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis
Henry, R. L., Mellis, C. M., & Petrovic, L. (1992) · Pediatric Pulmonology · doi:10.1002/ppul.1950120306 · Cited by 371
Sawa, T., Yahr, T. L., Ohara, M., Kurahashi, K., Gropper, M. A., Wiener-Kronish, J. P., & Frank, D. W. (1999) · Nature Medicine · doi:10.1038/7391 · Cited by 362
Bonfield, T. L., Konstan, M. W., Burfeind, P., Panuska, J. R., Hilliard, J. B., & Berger, M. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.13.3.7544594 · Cited by 360
Determinants of Mortality from Cystic Fibrosis in Canada, 1970-1989
Corey, M., & Farewell, V. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008664 · Cited by 360
Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis
Armstrong, D. S., Grimwood, K., Carzino, R., Carlin, J. B., Olinsky, A., & Phelan, P. D. (1995) · BMJ · doi:10.1136/bmj.310.6994.1571 · Cited by 357
Kahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357
Quantitation of Inflammatory Responses to Bacteria in Young Cystic Fibrosis and Control Patients
MUHLEBACH, M. S., STEWART, P. W., LEIGH, M. W., & NOAH, T. L. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9808096 · Cited by 354
Dasenbrook, E. C. (2010) · JAMA · doi:10.1001/jama.2010.791 · Cited by 353
Saiman, L., & Prince, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116779 · Cited by 349
A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis
Eigen, H., Rosenstein, B. J., FitzSimmons, S., & Schidlow, D. V. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70343-8 · Cited by 344
D'Argenio, D. A., Wu, M., Hoffman, L. R., Kulasekara, H. D., Déziel, E., Smith, E. E., Nguyen, H., Ernst, R. K., Larson Freeman, T. J., Spencer, D. H., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05678.x · Cited by 342
Balough, K., McCubbin, M., Weinberger, M., Smits, W., Ahrens, R., & Fick, R. (1995) · Pediatric Pulmonology · doi:10.1002/ppul.1950200203 · Cited by 339
Winstanley, C., Langille, M. G. I., Fothergill, J. L., Kukavica-Ibrulj, I., Paradis-Bleau, C., Sanschagrin, F., Thomson, N. R., Winsor, G. L., Quail, M. A., Lennard, N., et al. (2009) · Genome Research · doi:10.1101/gr.086082.108 · Cited by 339
Biofilm resistance to antimicrobial agents
Xu, K. D., McFeters, G. A., & Stewart, P. S. (2000) · Microbiology · doi:10.1099/00221287-146-3-547 · Cited by 325
Infection Control in Cystic Fibrosis
Saiman, L., & Siegel, J. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.57-71.2004 · Cited by 324
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
Langton Hewer, S. C., & Smyth, A. R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004197.pub4 · Cited by 324
Roux, A.-L., Catherinot, E., Ripoll, F., Soismier, N., Macheras, E., Ravilly, S., Bellis, G., Vibet, M.-A., Le Roux, E., Lemonnier, L., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01257-09 · Cited by 322
Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases.
Eh, O., & Esterly, J. R. (1975) · PubMed · Cited by 321
Vanlaere, E., Baldwin, A., Gevers, D., Henry, D., De Brandt, E., LiPuma, J. J., Mahenthiralingam, E., Speert, D. P., Dowson, C., & Vandamme, P. (2009) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijs.0.001123-0 · Cited by 321
Persistent Methicillin-resistant Staphylococcus aureus and Rate of FEV 1 Decline in Cystic Fibrosis
Dasenbrook, E. C., Merlo, C. A., Diener-West, M., Lechtzin, N., & Boyle, M. P. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-327oc · Cited by 319
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P. M., Jones, G., & Bruce, K. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5176-5183.2004 · Cited by 318
Jensen, T., Pedersen, S. S., Garne, S., Heilmann, C., Høiby, N., & Koch, C. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/19.6.831 · Cited by 314
Sibley, C. D., Parkins, M. D., Rabin, H. R., Duan, K., Norgaard, J. C., & Surette, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804326105 · Cited by 312
Smith, A. L., Fiel, S. B., Mayer-Hamblett, N., Ramsey, B., & Burns, J. L. (2003) · Chest · doi:10.1378/chest.123.5.1495 · Cited by 307
Richman-Eisenstat, J. B., Jorens, P. G., Hebert, C. A., Ueki, I., & Nadel, J. A. (1993) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1993.264.4.l413 · Cited by 307
Kerem, E., Corey, M., Gold, R., & Levison, H. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82653-8 · Cited by 306
Amitani, R., Wilson, R., Rutman, A., Read, R., Ward, C., Burnett, D., Stockley, R. A., & Cole, P. J. (1991) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/4.1.26 · Cited by 305
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
Döring, G., & Hoiby, N. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.03.008 · Cited by 304
ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSIS
Auerbach, H., Kirkpatrick, J., Williams, M., & Colten, H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92929-0 · Cited by 302
Erickson, D. L., Endersby, R., Kirkham, A., Stuber, K., Vollman, D. D., Rabin, H. R., Mitchell, I., & Storey, D. G. (2002) · Infection and Immunity · doi:10.1128/iai.70.4.1783-1790.2002 · Cited by 302
Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression
Hoffman, L. R., Kulasekara, H. D., Emerson, J., Houston, L. S., Burns, J. L., Ramsey, B. W., & Miller, S. I. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.09.006 · Cited by 301
Armstrong, D. S., Grimwood, K., Carlin, J. B., Carzino, R., Olinsky, A., & Phenlan, P. D. (1996) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199605)21:5<267::aid-ppul1>3.0.co;2-k · Cited by 301
Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence
Davies, J. C. (2002) · Paediatric Respiratory Reviews · doi:10.1016/s1526-0550(02)00003-3 · Cited by 300
Ratjen, F., Munck, A., Kho, P., Angyalosi, G., & for the ELITE Study Group (2010) · Thorax · doi:10.1136/thx.2009.121657 · Cited by 291
Characterization of Colony Morphology Variants Isolated from Pseudomonas aeruginosa Biofilms
Kirisits, M. J., Prost, L., Starkey, M., & Parsek, M. R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.8.4809-4821.2005 · Cited by 290
Tosi, M. F., Zakem, H., & Berger, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114699 · Cited by 289
Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection
Demko, C. A., Byard, P. J., & Davis, P. B. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00230-n · Cited by 289
A major Pseudomonas aeruginosa clone common to patients and aquatic habitats
Römling, U., Wingender, J., Müller, H., & Tümmler, B. (1994) · Applied and Environmental Microbiology · doi:10.1128/aem.60.6.1734-1738.1994 · Cited by 287
Boucher, J. C., Yu, H., Mudd, M. H., & Deretic, V (1997) · Infection and Immunity · doi:10.1128/iai.65.9.3838-3846.1997 · Cited by 282
Son, M. S., Matthews, W. J., Kang, Y., Nguyen, D. T., & Hoang, T. T. (2007) · Infection and Immunity · doi:10.1128/iai.01807-06 · Cited by 280
Allergic bronchopulmonary aspergillosis in cystic fibrosis
Laufer, P., Fink, J. N., Bruns, W. T., Unger, G. F., Kalbfleisch, J. H., Greenberger, P. A., & Patterson, R. (1984) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(84)90482-2 · Cited by 278
Hodson, M., Penketh, A. R. L., & Batten, J. C. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90588-2 · Cited by 275
Baltimore, R. S., Christie, C. D. C., & Smith, G. J. W. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.6.1650 · Cited by 274
Clinical Significance of Scedosporium apiospermum in Patients with Cystic Fibrosis
Cimon, B., Carrère, J., Vinatier, J. F., Chazalette, J. P., Chabasse, D., & Bouchara, J. P. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050011 · Cited by 271
Oliver, A., Baquero, F., & Blázquez, J. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02855.x · Cited by 267
Coenye, T., Goris, J., Spilker, T., Vandamme, P., & LiPuma, J. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.6.2062-2069.2002 · Cited by 264
Bedrossian, C. W. M., Donald Greenberg, S., Singer, D. B., Hansen, J. J., & Rosenberg, H. S. (1976) · Human Pathology · doi:10.1016/s0046-8177(76)80023-8 · Cited by 262
Sibley, C. D., Duan, K., Fischer, C., Parkins, M. D., Storey, D. G., Rabin, H. R., & Surette, M. G. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000184 · Cited by 261
Bjarnsholt, T., Jensen, P. Ø., Jakobsen, T. H., Phipps, R., Nielsen, A. K., Rybtke, M. T., Tolker-Nielsen, T., Givskov, M., Høiby, N., Ciofu, O., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010115 · Cited by 261
ARIS, R. M., ROUTH, J. C., LiPUMA, J. J., HEATH, D. G., & GILLIGAN, P. H. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2107022 · Cited by 256
Kelley, T. J., & Drumm, M. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2357 · Cited by 255
The Role of Inflammation in the Pathophysiology of CF Lung Disease
Chmiel, J. F., Berger, M., & Konstan, M. W. (2002) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:23:1:005 · Cited by 255
Bragonzi, A., Paroni, M., Nonis, A., Cramer, N., Montanari, S., Rejman, J., Di Serio, C., Döring, G., & Tümmler, B. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1943oc · Cited by 255
PIER, G. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.03.012 · Cited by 253
SPONTANEOUS MUTATORS IN BACTERIA: Insights into Pathways of Mutagenesis and Repair
Miller, J. H. (1996) · Annual Review of Microbiology · doi:10.1146/annurev.micro.50.1.625 · Cited by 253
Valenza, G., Tappe, D., Turnwald, D., Frosch, M., König, C., Hebestreit, H., & Abele-Horn, M. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2007.06.006 · Cited by 251
Mena, A., Smith, E. E., Burns, J. L., Speert, D. P., Moskowitz, S. M., Perez, J. L., & Oliver, A. (2008) · Journal of Bacteriology · doi:10.1128/jb.01147-08 · Cited by 251
Ciofu, O., Riis, B., Pressler, T., Poulsen, H. E., & Høiby, N. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2276-2282.2005 · Cited by 251
Epidemiology Of Chronic Pseudomonas aeruginosa Infections In Cystic Fibrosis
Romling, U., Fiedler, B., Bosshammer, J., Grothues, D., Greipel, J., von der Hardt, H., & Tummler, B. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1616 · Cited by 250
Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis
Jones, A. M. (2004) · Thorax · doi:10.1136/thx.2003.017210 · Cited by 250
von Eiff, C., Bettin, D., Proctor, R. A., Rolauffs, B., Lindner, N., Winkelmann, W., & Peters, G. (1997) · Clinical Infectious Diseases · doi:10.1086/516962 · Cited by 247
Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study
Mastella, G., Rainisio, M., Harms, H. K., Hodson, M. E., Koch, C., Navarro, J., Strandvik, B., McKenzie, S. G., & the investigators of the Epidemiologic Registry of Cystic Fibrosis, O. B. O. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.016003464.x · Cited by 244
Høiby, N., Flensborg, E. W., Beck, B., Friis, B., JACOBSEN, S. V., & Jacobsen, L. (1977) · PubMed · Cited by 244
Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen, S. S., Hoiby, N., Espersen, F., & Koch, C. (1992) · Thorax · doi:10.1136/thx.47.1.6 · Cited by 240
The role of respiratory viruses in cystic fibrosis
Wat, D., Gelder, C., Hibbitts, S., Cafferty, F., Bowler, I., Pierrepoint, M., Evans, R., & Doull, I. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2007.12.002 · Cited by 240
Small-Colony Variants of Pseudomonas aeruginosa in Cystic Fibrosis
Rohde, M. (1999) · Clinical Infectious Diseases · doi:10.1086/598644 · Cited by 238
Abman, S. H., Ogle, J. W., Butler-Simon, N., Rumack, C. M., & Accurso, F. J. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80008-8 · Cited by 237
Wang, E. E. L., Prober, C. G., Manson, B., Corey, M., & Levison, H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198412273112602 · Cited by 235
Increased mutability of Pseudomonas aeruginosa in biofilms
Driffield, K., Miller, K., Bostock, J. M., O'Neill, A. J., & Chopra, I. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn044 · Cited by 234
Inflammation, Infection, and Pulmonary Function in Infants and Young Children with Cystic Fibrosis
DAKIN, C. J., NUMA, A. H., WANG, H., MORTON, J. R., VERTZYAS, C. C., & HENRY, R. L. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2010139 · Cited by 233
SZAFF, M., HØIBY, N., & FLENSBORG, E. W. (1983) · Acta Paediatrica · doi:10.1111/j.1651-2227.1983.tb09789.x · Cited by 233
Infection with Burkholderia cepacia in Cystic Fibrosis: Outcome Following Lung Transplantation
CHAPARRO, C., MAURER, J., GUTIERREZ, C., KRAJDEN, M., CHAN, C., WINTON, T., KESHAVJEE, S., SCAVUZZO, M., TULLIS, E., HUTCHEON, M., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.9811076 · Cited by 232
Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection
Häußler, S., Ziegler, I., Löttel, A., Götz, F. V., Rohde, M., Wehmhöhner, D., Saravanamuthu, S., Tümmler, B., & Steinmetz, I. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05069-0 · Cited by 228
Schurr, M. J., Yu, H. D., Martı́nez-Salazar, J. M., Boucher, J. C., & Deretic, V. P. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.16.4997-5004.1996 · Cited by 228
Inactivation of Human β-Defensins 2 and 3 by Elastolytic Cathepsins
Taggart, C. C., Greene, C. M., Smith, S. G., Levine, R. L., McCray, P. B., O’Neill, S., & McElvaney, N. G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.931 · Cited by 226
Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005
Razvi, S., Quittell, L., Sewall, A., Quinton, H., Marshall, B., & Saiman, L. (2009) · Chest · doi:10.1378/chest.09-0132 · Cited by 225
SWINGS, J., DE VOS, P., VAN den MOOTER, M., & DE LEY, J. (1983) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-33-2-409 · Cited by 225
Analysis of quorum sensing-deficient clinical isolates of Pseudomonas aeruginosa
Schaber, J. A., Carty, N. L., McDonald, N. A., Graham, E. D., Cheluvappa, R., Griswold, J. A., & Hamood, A. N. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45617-0 · Cited by 224
Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients
Bittar, F., Richet, H., Dubus, J.-C., Reynaud-Gaubert, M., Stremler, N., Sarles, J., Raoult, D., & Rolain, J.-M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002908 · Cited by 224
Rogers, G. B., Hart, C. A., Mason, J. R., Hughes, M., Walshaw, M. J., & Bruce, K. D. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3548-3558.2003 · Cited by 223
Molecular Epidemiology of Mycobacterium abscessus, with Focus on Cystic Fibrosis
Jönsson, B. E., Gilljam, M., Lindblad, A., Ridell, M., Wold, A. E., & Welinder-Olsson, C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02592-06 · Cited by 222
Mahenthiralingam, E., Vandamme, P., Campbell, M. E., Henry, D. A., Gravelle, A. M., Wong, L. T. K., Davidson, A. G. F., Wilcox, P. G., Nakielna, B., & Speert, D. P. (2001) · Clinical Infectious Diseases · doi:10.1086/322684 · Cited by 222
Dean, T. P., Dai, Y., Shute, J. K., Church, M. K., & Warner, J. O. (1993) · Pediatric Research · doi:10.1203/00006450-199308000-00010 · Cited by 221
Pulmonary infections in patients with cystic fibrosis
RAJAN, S. (2002) · Seminars in Respiratory Infections · doi:10.1053/srin.2002.31690 · Cited by 220
Sagel, S. D., Gibson, R. L., Emerson, J., McNamara, S., Burns, J. L., Wagener, J. S., & Ramsey, B. W. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.08.001 · Cited by 219
Gao, W., Chua, K., Davies, J. K., Newton, H. J., Seemann, T., Harrison, P. F., Holmes, N. E., Rhee, H.-W., Hong, J.-I., Hartland, E. L., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000944 · Cited by 218
Klepac‐Ceraj, V., Lemon, K. P., Martin, T. R., Allgaier, M., Kembel, S. W., Knapp, A. A., Lory, S., Brodie, E. L., Lynch, S. V., Bohannan, B. J. M., et al. (2010) · Environmental Microbiology · doi:10.1111/j.1462-2920.2010.02173.x · Cited by 218
Baldwin, A., Mahenthiralingam, E., Thickett, K. M., Honeybourne, D., Maiden, M. C. J., Govan, J. R., Speert, D. P., LiPuma, J. J., Vandamme, P., & Dowson, C. G. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4665-4673.2005 · Cited by 217
Effects of Viral Lower Respiratory Tract Infection on Lung Function in Infants With Cystic Fibrosis
Hiatt, P. W., Grace, S. C., Kozinetz, C. A., Raboudi, S. H., Treece, D. G., Taber, L. H., & Piedra, P. A. (1999) · Pediatrics · doi:10.1542/peds.103.3.619 · Cited by 215
Update on the Burkholderia cepacia complex
LiPuma, J. J. (2005) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000181475.85187.ed · Cited by 215
Burkholderia cepacia complex infection in patients with cystic fibrosis
MAHENTHIRALINGAM, E., BALDWIN, A., & VANDAMME, P. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-7-533 · Cited by 214
Vandamme, P. (2002) · FEMS Immunology and Medical Microbiology · doi:10.1016/s0928-8244(02)00301-2 · Cited by 213
PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS
Hoiby, N., Andersen, V., & Bendixen, G. (1975) · Acta Pathologica Microbiologica Scandinavica Section C Immunology · doi:10.1111/j.1699-0463.1975.tb01665.x · Cited by 212
Sanguinetti, M., Ardito, F., Fiscarelli, E., La Sorda, M., D'Argenio, P., Ricciotti, G., & Fadda, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.2.816-819.2001 · Cited by 210
Johansen, H. K., & Hoiby, N. (1992) · Thorax · doi:10.1136/thx.47.2.109 · Cited by 205
Aspergillosis and atopy in cystic fibrosis.
Nelson, L. A., Callerame, M., & Schwartz, R. H. (1979) · PubMed · doi:10.1164/arrd.1979.120.4.863 · Cited by 205
Staphylococcal Small Colony Variants Have Novel Mechanisms for Antibiotic Resistance
Proctor, R. A., Kahl, B., von Eiff, C., Vaudaux, P. E., Lew, D. P., & Peters, G. (1998) · Clinical Infectious Diseases · doi:10.1086/514906 · Cited by 204
Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.
Thomassen, M. J., Demko, C. A., Klinger, J. D., & Stern, R. C. (1985) · PubMed · doi:10.1164/arrd.1985.131.5.791 · Cited by 202
Fick, R. B., Naegel, G. P., Squier, S. U., Wood, R. E., Gee, J. B., & Reynolds, H. Y. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111407 · Cited by 201
Cited by
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Rumbaugh, K. P., & Sauer, K. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0385-0 · Cited by 907
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Reynolds, D., & Kollef, M. (2021) · Drugs · doi:10.1007/s40265-021-01635-6 · Cited by 721
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
Folkesson, A., Jelsbak, L., Yang, L., Johansen, H. K., Ciofu, O., Høiby, N., & Molin, S. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2907 · Cited by 715
Lipopolysaccharide modification in Gram-negative bacteria during chronic infection
Maldonado, R. F., Sá-Correia, I., & Valvano, M. A. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw007 · Cited by 689
Metadata
- Authors
- Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2011-01
- Volume
- 24
- Issue
- 1
- Pages
- 29-70
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2100669918
- Cited by
- 411
- References
- 516
- FWCI
- 25.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.